DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cogentin (Benztropine) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Cogentin (Benztropine) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (28)
Death (2)
Life Threatening Events (3)

Reports by Reaction Type

Depression (12)Muscle Spasms (11)Gait Disturbance (11)Tardive Dyskinesia (11)Movement Disorder (10)Pain (10)Muscle Tightness (10)Abnormal Behaviour (10)Weight Decreased (9)Drug Ineffective (9)Musculoskeletal Disorder (9)Adverse Event (9)

Possible Cogentin side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-20

Patient: female

Reactions: Salivary Hypersecretion

Drug(s) suspected as cause:
Ativan

Lithium Carbonate

Cogentin

Trifluoperazine HCL



Possible Cogentin side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-06

Patient: male

Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Tardive Dyskinesia, Extrapyramidal Disorder, Gait Disturbance, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Zyprexa
    Indication: Schizophrenia

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01



Possible Cogentin side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-03

Patient:

Reactions: Product Quality Issue, Akathisia, Fatigue, Sleep Disorder, Panic Disorder

Drug(s) suspected as cause:
Invega Sustenna
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-01

Risperdal Consta
    Indication: Product Used FOR Unknown Indication

Cogentin
    Indication: Akathisia

Other drugs received by patient: Wellbutrin XL; Ativan



Possible Cogentin side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-01

Patient: female

Reactions: Abdominal Pain, Abdominal Pain Upper

Drug(s) suspected as cause:
Cogentin
    Dosage: congentin 7mg 2/day mouth
    Administration route: Oral
    Indication: Depression
    Start date: 2012-07-24
    End date: 2012-07-30

Depakote
    Dosage: depakote 500 mg 1/day mouth
    Administration route: Oral
    Start date: 2012-07-24
    End date: 2012-07-30

Abilify
    Dosage: 1/day mouth
    Administration route: Oral



Possible Cogentin side effects in 51 year old female

Reported by a consumer/non-health professional from United States on 2012-07-27

Patient: 51 year old female, weighing 68.0 kg (149.6 pounds)

Reactions: Depression

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Seroquel XR
    Administration route: Oral
    Indication: Bipolar II Disorder

Cogentin

Synthroid

Seroquel XR
    Administration route: Oral
    Indication: Depression

Klonopin

Wellbutrin

Cymbalta



Possible Cogentin side effects in male

Reported by a consumer/non-health professional from United States on 2012-07-03

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Disturbance in Attention, Suicide Attempt, Tardive Dyskinesia, Gait Disturbance, Extrapyramidal Disorder, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Zyprexa
    Indication: Schizophrenia

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02



Possible Cogentin side effects in male

Reported by a consumer/non-health professional from United States on 2012-06-26

Patient: male, weighing 72.6 kg (159.7 pounds)

Reactions: Scoliosis, Neuropathy Peripheral, Schizophrenia, Paralysis, Muscle Spasms

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2011-12-01
    End date: 2012-02-01

Risperdal Consta
    Indication: Schizophrenia
    Start date: 2005-01-01
    End date: 2011-01-01

Risperdal Consta

Risperdal Consta
    Indication: Bipolar I Disorder
    End date: 2011-01-01

Risperdal Consta
    Start date: 2011-11-01
    End date: 2011-12-01

Risperdal Consta

Risperdal Consta
    Start date: 2005-01-01
    End date: 2011-01-01

Risperdal Consta
    Start date: 2005-01-01

Risperdal Consta
    End date: 2011-01-01

Risperdal Consta
    Start date: 2005-01-01

Flexeril
    Administration route: Oral
    Indication: Scoliosis
    Start date: 2012-02-24

Risperdal Consta
    Start date: 2011-11-01
    End date: 2011-12-01

Benadryl
    Indication: Adverse Drug Reaction
    Start date: 2011-01-01
    End date: 2011-01-01

Risperdal Consta
    Start date: 2011-12-01
    End date: 2012-02-01

Cogentin
    Indication: Adverse Drug Reaction
    Start date: 2011-01-01
    End date: 2011-01-01

Neurontin
    Indication: Neuropathy Peripheral

Vicodin
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Invega Sustenna; Invega Sustenna



Possible Cogentin side effects in male

Reported by a physician from United States on 2012-06-26

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Zyprexa
    Indication: Schizophrenia

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01



Possible Cogentin side effects in male

Reported by a consumer/non-health professional from United States on 2012-06-25

Patient: male, weighing 65.8 kg (144.7 pounds)

Reactions: Trismus, Pain, Swollen Tongue, Headache, Muscle Tightness, Anxiety, Thinking Abnormal, Sensory Disturbance, Depression

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cogentin
    Indication: Product Used FOR Unknown Indication

Invega
    Administration route: Oral
    Start date: 2010-01-01

Invega
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2012-06-04
    End date: 2012-06-04



Possible Cogentin side effects in male

Reported by a consumer/non-health professional from United States on 2012-06-18

Patient: male, weighing 117.9 kg (259.5 pounds)

Reactions: Confusional State, Anxiety, Depression, Somnolence

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral
    Start date: 2012-01-01

Invega Sustenna
    Indication: Bipolar I Disorder
    Start date: 2012-04-01

Cogentin
    Administration route: Oral
    Indication: Bipolar I Disorder
    Start date: 2012-04-01

Depakote ER
    Administration route: Oral
    Indication: Bipolar I Disorder
    Start date: 2012-04-01

Risperdal
    Administration route: Oral
    Indication: Bipolar I Disorder
    Start date: 2012-04-01
    End date: 2012-01-01



Possible Cogentin side effects in male

Reported by a physician from United States on 2012-06-05

Patient: male

Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Injury, Muscle Spasms, Inappropriate Schedule of Drug Administration, Back Pain, Dysphagia, Dystonia, Grimacing, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension

Drug(s) suspected as cause:
Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Zyprexa
    Indication: Schizophrenia



Possible Cogentin side effects in male

Reported by a physician from United States on 2012-05-31

Patient: male

Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Extrapyramidal Disorder, Hypertension

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Zyprexa
    Indication: Schizophrenia

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02



Possible Cogentin side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-29

Patient: male

Reactions: Confusional State, Anxiety, Abnormal Behaviour, Disorientation, Cognitive Disorder, Gait Disturbance

Drug(s) suspected as cause:
Invega Sustenna
    Indication: Psychotic Disorder

Klonopin
    Indication: Anxiety

Invega Sustenna
    Start date: 2012-02-17

Klonopin
    Start date: 2011-08-01
    End date: 2012-02-01

Cogentin
    Indication: Product Used FOR Unknown Indication



Possible Cogentin side effects in male

Reported by a consumer/non-health professional from United States on 2012-05-15

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Extrapyramidal Disorder, Hypertension

Drug(s) suspected as cause:
Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Zyprexa
    Indication: Schizophrenia

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02



Possible Cogentin side effects in male

Reported by a consumer/non-health professional from United States on 2012-04-27

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Inappropriate Schedule of Drug Administration, Back Pain, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Extrapyramidal Disorder, Gait Disturbance, Tardive Dyskinesia, Hypertension

Drug(s) suspected as cause:
Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Zyprexa
    Indication: Schizophrenia

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02



Possible Cogentin side effects in male

Reported by a consumer/non-health professional from United States on 2012-04-05

Patient: male

Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Bipolar Disorder
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2009-01-01

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Major Depression
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Zyprexa
    Indication: Schizophrenia

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01



Possible Cogentin side effects in male

Reported by a consumer/non-health professional from United States on 2012-03-23

Patient: male, weighing 95.3 kg (209.6 pounds)

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Hypertension

Drug(s) suspected as cause:
Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Bipolar Disorder
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Major Depression
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Zyprexa
    Indication: Schizophrenia

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Dosage: ndc 050468-306

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: ndc 050468-306

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal Consta
    Dosage: ndc 050468-306

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01



Possible Cogentin side effects in male

Reported by a consumer/non-health professional from United States on 2012-03-22

Patient: male, weighing 72.6 kg (159.7 pounds)

Reactions: Neuropathy Peripheral, Paralysis, Schizophrenia, Muscle Spasms

Drug(s) suspected as cause:
Flexeril
    Administration route: Oral
    Indication: Scoliosis
    Start date: 2012-02-24

Vicodin
    Indication: Product Used FOR Unknown Indication

Risperdal Consta
    Start date: 2005-01-01
    End date: 2011-01-01

Risperdal Consta
    Start date: 2005-01-01

Risperdal Consta
    Start date: 2005-01-01
    End date: 2011-01-01

Risperdal Consta
    Start date: 2011-11-01
    End date: 2011-12-01

Risperdal Consta
    End date: 2011-01-01

Risperdal Consta
    Start date: 2005-01-01

Risperdal Consta
    Indication: Bipolar I Disorder

Risperdal Consta
    Start date: 2011-12-01
    End date: 2012-02-01

Cogentin
    Indication: Adverse Drug Reaction
    Start date: 2011-01-01
    End date: 2011-01-01

Risperdal Consta
    End date: 2011-01-01

Risperdal Consta
    Start date: 2011-11-01
    End date: 2011-12-01

Risperdal Consta
    Start date: 2011-12-01
    End date: 2012-02-01

Benadryl
    Indication: Adverse Drug Reaction
    Start date: 2011-01-01
    End date: 2011-01-01

Risperdal Consta
    Indication: Schizophrenia

Neurontin
    Indication: Neuropathy Peripheral

Other drugs received by patient: Invega Sustenna; Invega Sustenna



Possible Cogentin side effects in 26 year old

Reported by a physician from United States on 2012-03-15

Patient: 26 year old

Reactions: Movement Disorder, Laboratory Test Abnormal, Restlessness

Drug(s) suspected as cause:
Invega
    Administration route: Oral
    Start date: 2010-09-01
    End date: 2011-09-01

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type

Cogentin
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-09-01



Possible Cogentin side effects in 37 year old female

Reported by a physician from United States on 2012-03-02

Patient: 37 year old female, weighing 63.5 kg (139.7 pounds)

Reactions: Restlessness, Urinary Retention, Gait Disturbance, Feeling Abnormal, Tremor

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cogentin
    Dosage: 1.0 mg
    Administration route: Oral
    Indication: Restlessness
    Start date: 2011-01-01
    End date: 2011-05-01

Cogentin
    Dosage: 1.0 mg
    Administration route: Oral
    Indication: Tremor
    Start date: 2011-01-01
    End date: 2011-05-01



Possible Cogentin side effects in female

Reported by a consumer/non-health professional from United States on 2012-02-01

Patient: female

Reactions: Septic Shock, Stevens-Johnson Syndrome

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral
    Indication: Depression
    Start date: 2009-05-01

Risperdal
    Administration route: Oral
    Indication: Bipolar Disorder
    Start date: 2009-05-01

Cogentin
    Indication: Product Used FOR Unknown Indication



Possible Cogentin side effects in female

Reported by a consumer/non-health professional from United States on 2012-01-23

Patient: female

Reactions: Stevens-Johnson Syndrome

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral
    Indication: Bipolar Disorder
    Start date: 2009-05-01

Risperdal
    Administration route: Oral
    Indication: Depression
    Start date: 2009-05-01

Cogentin
    Indication: Product Used FOR Unknown Indication



Possible Cogentin side effects in male

Reported by a consumer/non-health professional from United States on 2011-12-16

Patient: male

Reactions: Tardive Dyskinesia

Drug(s) suspected as cause:
Cogentin

Abilify
    Dosage: also 5mg/d 10mg dose for 6 months



Possible Cogentin side effects in 48 year old male

Reported by a consumer/non-health professional from United States on 2011-12-16

Patient: 48 year old male

Reactions: Tardive Dyskinesia

Drug(s) suspected as cause:
Cogentin

Abilify
    Dosage: initially given 10mg,then increased to 15mg,the again reduced to 2mg
    Indication: Psychotic Disorder

Aricept



Possible Cogentin side effects in 66 year old female

Reported by a consumer/non-health professional from United States on 2011-11-11

Patient: 66 year old female

Reactions: Drug Hypersensitivity

Drug(s) suspected as cause:
Morphine
    Dosage: unk

Cogentin
    Dosage: unk

Other drugs received by patient: Wellbutrin; Geodon; Synthroid; Zocor; Inderal; Primidone



Possible Cogentin side effects in female

Reported by a consumer/non-health professional from United States on 2011-10-26

Patient: female

Reactions: Salivary Hypersecretion

Drug(s) suspected as cause:
Stelazine

Ativan

Cogentin
    Dosage: 0.5 mg

Lithium Carbonate



Possible Cogentin side effects in 26 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-11

Patient: 26 year old male

Reactions: Weight Increased, Eye Movement Disorder, Cognitive Disorder

Drug(s) suspected as cause:
Invega Sustenna
    Indication: Schizophrenia
    Start date: 2011-03-01

Cogentin
    Administration route: Oral
    Indication: Eye Movement Disorder
    Start date: 2011-06-01



Possible Cogentin side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-10

Patient: male

Reactions: Cognitive Disorder

Drug(s) suspected as cause:
Invega Sustenna
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-01-01

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014